Registry for Treatment of Upper Urinary Tract Tumours
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02281188|
Recruitment Status : Recruiting
First Posted : November 3, 2014
Last Update Posted : February 4, 2019
|Condition or disease|
|Upper Urinary Tract Tumours|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||3000 participants|
|Target Follow-Up Duration:||10 Years|
|Official Title:||Registry for Treatment of Upper Urinary Tract Tumours; A Multi-Center, International Registry to Evaluate the Treatment of Upper Tract Urothelial Cancer: Incidence, Indications, Treatment Types and Outcomes.|
|Actual Study Start Date :||November 2014|
|Estimated Primary Completion Date :||February 2019|
|Estimated Study Completion Date :||February 2024|
- Recurrence rates for patients presenting with primary UTUC stratified for type of treatment [ Time Frame: 10 years ]
Data collection will be divided into the following categories: Patient / tumour characteristics, assessment, treatment choice and intra-operative details, post-operative details and complications, and follow up. The following lists all categories and type of data to be gathered.
Patient characteristics: demographics, risk factors, comorbidities and previous malignancies.
Assessment: symptoms, imaging type, cytology, TNM staging. Treatment choice and intra-operative details: date, use of endoscopy, type of scopes, type of imaging enhancement, biopsies, results, neo adjuvant treatment specifications and treatment type.
Intra-operative: date, duration, antibiotics, type of treatment, results. Post-operative: complications and Clavien-Dindo classification, instillation, adjuvant therapy, pathology.
Follow up: date, status (e.g. alive without cancer, alive with cancer), recurrence, diagnostics performed, cystoscopy, cytology, results.
- Intra- and postoperative complications (including Clavien-Dindo classification) [ Time Frame: 5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02281188
|Contact: Sonja van Rees Vellingaemail@example.com|
|Contact: Sonja van Rees Vellinga|
|Study Chair:||Jean de la Rosette||Clinical Research Office of the Endourological Society|